Row

A. Giza challenge, AnhuiVACC, I

B. Giza challenge, AnhuiVACC, II

C. Giza challenge, AnhuiVACC, III

D. Giza challenge, AnhuiVACC, IV

E. Giza challenge, AnhuiVACC, V

F. Giza challenge, AnhuiVACC, VI

Row

G. Giza challenge, AC-AnhuiVACC, I

H. Giza challenge, AC-AnhuiVACC, II

I. Giza challenge, AC-AnhuiVACC, III

J. Giza challenge, AC-AnhuiVACC, IV

K. Giza challenge, AC-AnhuiVACC, V

L. Giza challenge, AC-AnhuiVACC, VI

Row

M. Giza challenge, GizaVACC, I

N. Giza challenge, GizaVACC, II

O. Giza challenge, GizaVACC, III

P. Giza challenge, GizaVACC, IV

Q. Giza challenge, GizaVACC, V

R. Giza challenge, GizaVACC, VI

Row

Data S9. Individual antibody profiles of animals from the Giza vaccination-challenge study. Individual immune responses upon vaccination with A(H5N6) split-inactivated vaccines in the Giza challenge study. Individual animal data used to generate merged antibody profiles displayed in Fig. 3 and Data S8. For each HA vaccine antigen, the position, breadth, and height of individual sera are represented in the antigenic map from Fig. 1B. HA antigen present in vaccine: (A-F) AnhuiVACC, (G-L) AC-AnhuiVACC, and (M-R) GizaVACC. Using the same representation as Data S6. GMT: geometric mean titer.